EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Drude SILCS-Nucleic: harnessing explicit electronic polarization in targeting RNA and DNA for drug design

Haley M Michel, Anne M Brown, Alexander D MacKerell, Justin A Lemkul iD

Nucleic Acids Research · 2026

DOI: 10.1093/nar/gkag871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Haley M Michel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Virginia Tech, Blacksburg, VA 24061, United States. Hauptthemen laut MEDLINE: RNA, DNA, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, Department of Agriculture National Institute of Food and Agriculture, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing interest in nucleic acids as therapeutic targets has prompted the development of novel computational methods to facilitate drug discovery. In this study, we extend the Site Identification by Ligand Competitive Saturation (SILCS) methodology to characterize ligand–nucleic acid interactions using the Drude polarizable force field. We demonstrate the ability of the Drude force field to better model solute–nucleic acid interactions, resulting in improved identification of known binding sites and ligand binding favorability predictions across a diverse set of nucleic acid structures. This new workflow addresses limitations in previous SILCS studies by exploiting the enhanced sampling of solutes in the original SILCS-RNA workflow, accurately modeling the interactions of charged species, and improving solute sampling in minor groove binding sites. These results establish this Drude-based SILCS workflow as a valuable tool for structure-based drug design targeting nucleic acids and offer insights into solute preferences that can guide rational ligand design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNADNADrug DesignLigandsBinding SitesNucleic Acid ConformationModels, Molecular

Substanzen

RNALigandsDNA

Autor:innen und Institutionen

  • Department of Biochemistry, Virginia Tech, Blacksburg, VA 24061, United States.
  • University Libraries, Virginia Tech, Blacksburg, VA 24061, United States.
  • Center for Drug Discovery, Virginia Tech, Blacksburg, VA 24061, United States.
  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, United States.

ORCID-Profile: Justin A Lemkul

Förderung

  • NIH HHS
  • Department of Agriculture National Institute of Food and Agriculture
  • NIGMS NIH HHS
  • National Science Foundation
  • Expanse Cluster at San Diego Supercomputer Center
  • National Institutes of Health

Zitieren

APA

Michel, H. M., Brown, A. M., MacKerell, A. D., & Lemkul, J. A. (2026). Drude SILCS-Nucleic: harnessing explicit electronic polarization in targeting RNA and DNA for drug design. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag871

Vancouver

Michel HM, Brown AM, MacKerell AD, Lemkul JA. Drude SILCS-Nucleic: harnessing explicit electronic polarization in targeting RNA and DNA for drug design. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag871

BibTeX
@article{Michel2026,
  author = {Michel, Haley M and Brown, Anne M and MacKerell, Alexander D and Lemkul, Justin A},
  title = {Drude SILCS-Nucleic: harnessing explicit electronic polarization in targeting RNA and DNA for drug design},
  journal = {Nucleic Acids Research},
  year = {2026},
  doi = {10.1093/nar/gkag871}
}
Kostenlos starten →